Renal Impairment and Prognosis of Patients with Atrial Fibrillation Undergoing Coronary Intervention - The AFCAS Trial

• Heli M. Lahtela,

  Affiliation Heart Center, Turku University Hospital and University of Turku, Turku, Finland

  ⨯
• Tuomas O. Kiviniemi,

  Affiliation Heart Center, Turku University Hospital and University of Turku, Turku, Finland

  ⨯
• Marja K. Puurunen,

  Affiliation Hemostasis laboratory, Finnish Red Cross Blood Service, Helsinki, Finland

  ⨯
• Axel Schlitt,

  Affiliation Medical Faculty, Martin Luther University Halle-Wittenberg and Paracelsus-Harz-Clinic Bad Suderode, Halle, Germany

  ⨯
• Andrea Rubboli,

  Affiliation Division of Cardiology, Laboratory of Interventional Cardiology, Ospedale Maggiore, Bologna, Italy

  ⨯
• Antti Ylitalo,

  Affiliation Department of Internal Medicine, Lapland Central Hospital, Rovaniemi, Finland; Medical Research Center, University of Oulu, Oulu, Finland

  ⨯
• José Valencia,

  Affiliation Department of Cardiology, General Hospital University of Alicante, Alicante, Spain

  ⨯
• Gregory Y. H. Lip,

  Affiliation University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, United Kingdom

  ⨯
• K. E. Juhani Airaksinen

  * E-mail: juhani.airaksinen@tyks.fi

  Affiliation Heart Center, Turku University Hospital and University of Turku, Turku, Finland

  ⨯